Vebreltinib: clinical trials recruiting now
3
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 2
Phase 2 3
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer · Vebreltinib for Lung cancer | 3 |
| Non-Small-Cell Lung Cancer · Vebreltinib for Non-Small-Cell Lung Cancer | 3 |
Recruiting trials involving Vebreltinib
- Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression
- Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.
- Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI
Common questions
How many recruiting trials involve Vebreltinib?
3 recruiting trials across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.